Edwin D. Charlebois - Concepedia

Author

Edwin D. Charlebois

University of California, San Francisco ORCID

Also Known As

Byonanebye, Dathan, Charlebois, Edwin D., E Charlebois, E D Charlebois, E. Charlebois, E. D. Charlebois, EDWIN CHARLEBOIS, Edwin Charlebois, Edwin D Charlebois, Edwin D. Charlebois

276

Publications

15.5K

Citations

H-Index

156

Concepts

All Affiliations

University of California, San Francisco Makerere University San Francisco AIDS Foundation San Francisco General Hospital Infectious Diseases Research Collaboration

About

Edwin D. Charlebois is an author at University of California, San Francisco specializing in medicine, public health, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	37	4K
2	Health Sciences	6	6	962
3	Education	1	1	105
4	Engineering	1	1	15
5	Management	1	1	15

Edwin D. Charlebois

179

Publications

14.9K

Citations

H-Index

Page 1

	Year	Citations
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population David R. Bangsberg, Frederick Hecht, Edwin D. Charlebois, AIDS	2000	1K
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS David R. Bangsberg, Sharon Perry, Edwin D. Charlebois, AIDS Healthcare ProvisionPopulation Health SciencesHarm ReductionSubstance Use DisordersPreventive Medicine	2001	960
High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections Bradley W. Frazee, Jeremy V. Lynn, Edwin D. Charlebois, Annals of Emergency Medicine Soft Tissue InfectionsAntimicrobial SusceptibilityHealth SciencesEmergency Department SkinHealthcare-associated Infection	2004	497
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections Anne F. Luetkemeyer, Deborah Donnell, Julia C. Dombrowski, New England Journal of Medicine	2023	377
Measuring Adherence to Antiretroviral Therapy in a Diverse Population Using a Visual Analogue Scale Thomas P. Giordano, David Guzman, Richard A. Clark, HIV Clinical Trials	2004	349
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy Travis C. Porco, Jeffrey N. Martin, Kimberly Page, AIDS	2004	282
Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting Jessica H. Oyugi, Jayne Byakika-Tusiime, Edwin D. Charlebois, JAIDS Journal of Acquired Immune Deficiency Syndromes	2004	281
High levels of adherence do not prevent accumulation of HIV drug resistance mutations David R. Bangsberg, Edwin D. Charlebois, Robert M. Grant, AIDS	2003	256
Population-Based Community Prevalence of Methicillin-Resistant Staphylococcus aureus in the Urban Poor of San Francisco Edwin D. Charlebois, David R. Bangsberg, Noah Moss, Clinical Infectious Diseases Urban PoorUrban HealthCommunity MrsaAntibiotic ResistanceSan Francisco	2002	245
Community‐Adapted Methicillin‐Resistant<i>Staphylococcus aureus</i>(MRSA): Population Dynamics of an Expanding Community Reservoir of MRSA Heather A. Carleton, Binh An Diep, Edwin D. Charlebois, The Journal of Infectious Diseases Antibiotic ResistanceBacterial PathogensDrug ResistanceDisease ResistanceHealthcare-associated Infection	2004	231

Page 1